BackAcadia Healthcare Company Overview
Acadia Healthcare Company Inc

Acadia Healthcare Company Target Price

See Acadia Healthcare Company's analyst price targets ($32) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$31.67

Average Target Price

$32.352.1% upside

13 analysts in the last 4 months

High: $40 | Low: $24.5

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-30GuggenheimJason Cassorla$3923.1% upsideOpen
2026-07-30Barclays$321% upsideOpen
2026-07-20GuggenheimJason Cassorla$3820% upsideOpen
2026-07-14KeyBanc$4026.3% upsideOpen
2026-07-09UBS$3923.1% upsideOpen
2026-06-03JefferiesBrian Tanquilut$305.3% downsideOpen
2026-05-27KeyBancMatthew Gillmor$305.3% downsideOpen
2026-05-04RBC Capital$312.1% downsideOpen
2026-05-04Guggenheim$312.1% downsideOpen
2026-05-01Cantor Fitzgerald$305.3% downsideOpen
2026-04-30Barclays$2521.1% downsideOpen
2026-04-20Jefferies$24.522.6% downsideOpen
2026-04-17UBS$312.1% downsideOpen
2026-02-26Raymond JamesJohn Ransom$2521.1% downsideOpen
2026-02-26Leerink PartnersWhit Mayo$2230.5% downsideOpen
2026-02-23GuggenheimJason Cassorla$2230.5% downsideOpen
2026-01-22JefferiesBrian Tanquilut$1552.6% downsideOpen
2026-01-14RBC Capital$1746.3% downsideOpen
2025-12-18Mizuho Securities$1746.3% downsideOpen
2025-12-04BarclaysAndrew Mok$1455.8% downsideOpen
2025-12-03RBC Capital$1940% downsideOpen
2025-12-03Cantor Fitzgerald$1746.3% downsideOpen
2025-12-03Raymond JamesSarah James$1746.3% downsideOpen
2025-12-03UBS$2424.2% downsideOpen
2025-12-03KeyBancMatthew Gillmor$2521.1% downsideOpen
2025-12-03Leerink Partners$1455.8% downsideOpen
2025-12-03Deutsche BankPito Chickering$2036.8% downsideOpen
2025-11-07Raymond JamesSarah James$2230.5% downsideOpen
2025-10-08KeyBanc$3510.5% upsideOpen
2025-10-03Raymond JamesJohn Ransom$305.3% downsideOpen
2025-08-13Mizuho SecuritiesAnn Hynes$2230.5% downsideOpen
2025-08-13RBC CapitalBen Hendrix$2811.6% downsideOpen
2025-05-14KeyBancMatthew Gillmor$5573.7% upsideOpen
2025-03-03RBC Capital$4335.8% upsideOpen
2024-10-21Leerink PartnersWhit Mayo$87174.7% upsideOpen
2024-09-27BarclaysAndrew Mok$76140% upsideOpen
2024-08-01BarclaysAndrew Mok$83162.1% upsideOpen
2024-05-22RBC CapitalFrank Morgan$94196.8% upsideOpen
2024-05-03Mizuho SecuritiesAnn Hynes$70121% upsideOpen
2024-04-25Deutsche BankPito Chickering$70121% upsideOpen
2022-12-12RBC Capital$93193.7% upsideOpen
2022-08-26Leerink Partners$103225.2% upsideOpen
2022-08-01RBC Capital$94196.8% upsideOpen
2022-08-01Raymond James$100215.8% upsideOpen
2022-07-29Mizuho Securities$78146.3% upsideOpen
2022-07-29Barclays$85168.4% upsideOpen
2022-07-28UBS$90184.2% upsideOpen
2022-06-20Loop Capital MarketsJoseph France$72127.3% upsideOpen
2022-05-05Leerink Partners$95200% upsideOpen
2022-05-05Raymond James$85168.4% upsideOpen

Acadia Healthcare Company (ACHC) FAQ

Acadia Healthcare Company posts a target price of $32. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $32 for ACHC means covering analysts, on average, see the stock 2.1% upside of $31.67 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for ACHC's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Acadia Healthcare Company's other metric pages and overview cover the third.

Judging Acadia Healthcare Company against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $32 here, then scan peer and history charts to see if the gap is persistent.